These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 35086281)

  • 1. Anxiolytics in the treatment of central serous chorioretinopathy.
    Dudani AI; Dudani A; Dudani K; Dudani A
    Indian J Ophthalmol; 2022 Feb; 70(2):701. PubMed ID: 35086281
    [No Abstract]   [Full Text] [Related]  

  • 2. Anxiolytics and psychotropic medications in central serous chorioretinopathy: Caveats and concerns.
    Jain M
    Indian J Ophthalmol; 2022 Feb; 70(2):700-701. PubMed ID: 35086280
    [No Abstract]   [Full Text] [Related]  

  • 3. Anxiolytics in the treatment of central serous chorioretinopathy.
    Dudani AI; Dudani A; Dudani K; Dudani A
    Indian J Ophthalmol; 2021 Oct; 69(10):2902-2903. PubMed ID: 34571681
    [No Abstract]   [Full Text] [Related]  

  • 4. Commentary: Retinal pigment epithelial leak identification in central serous chorioretinopathy: Is fundus fluorescein angiography a must?
    Delhiwala K; Khamar B
    Indian J Ophthalmol; 2022 Mar; 70(3):895-896. PubMed ID: 35225538
    [No Abstract]   [Full Text] [Related]  

  • 5. Can we classify central serous chorioretinopathy better? Yes we can.
    Lotery A
    Eye (Lond); 2022 Mar; 36(3):487. PubMed ID: 34645968
    [No Abstract]   [Full Text] [Related]  

  • 6. Light exposure in acute central serous chorioretinopathy.
    Norouzpour A
    Eye (Lond); 2022 Jan; 36(1):243. PubMed ID: 33423042
    [No Abstract]   [Full Text] [Related]  

  • 7. Salivary Alpha-Amylase Levels May Correlate With Central Serous Chorioretinopathy Activity.
    Abdelhakim AH; Ledesma-Gil G; Yannuzzi LA
    Retina; 2021 Oct; 41(10):2007-2008. PubMed ID: 34292223
    [No Abstract]   [Full Text] [Related]  

  • 8. Macular Star Associated with Fibrinous Central Serous Chorioretinopathy.
    Hara C; Wakabayashi T; Nishida K
    Ophthalmology; 2023 Jan; 130(1):76. PubMed ID: 35773069
    [No Abstract]   [Full Text] [Related]  

  • 9. Acute Versus Chronic Central Serous Chorioretinopathy: Classification Strategies and Management.
    Arora S; Chhablani J; Hariprasad SM
    Ophthalmic Surg Lasers Imaging Retina; 2022 Aug; 53(8):418-420. PubMed ID: 35951715
    [No Abstract]   [Full Text] [Related]  

  • 10. Central serous chorioretinopathy: a personal perspective.
    Yannuzzi LA
    Am J Ophthalmol; 2010 Mar; 149(3):361-363. PubMed ID: 20172062
    [No Abstract]   [Full Text] [Related]  

  • 11. What Can We Learn From the Surprising Insight Into the Genetic Background of Age-Related Macular Degeneration and Central Serous Chorioretinopathy?
    Khateb S; Chowers I; Grunin M
    JAMA Ophthalmol; 2023 May; 141(5):457-458. PubMed ID: 37079325
    [No Abstract]   [Full Text] [Related]  

  • 12. Fluorescein angiography-guided photodynamic therapy with half-dose verteporfin for chronic central serous chorioretinopathy.
    Koytak A; Erol K; Coskun E; Asik N; Öztürk H; Özertürk Y
    Retina; 2010; 30(10):1698-703. PubMed ID: 20539254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinal microstructural abnormalities in central serous chorioretinopathy and polypoidal choroidal vasculopathy.
    Ooto S; Tsujikawa A; Mori S; Tamura H; Yamashiro K; Otani A; Yoshimura N
    Retina; 2011 Mar; 31(3):527-34. PubMed ID: 20890237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose rifampin as maintenance therapy in chronic central serous chorioretinopathy.
    Mattingly JJ; Amram AL; El-Annan J
    Can J Ophthalmol; 2018 Oct; 53(5):e182-e183. PubMed ID: 30340736
    [No Abstract]   [Full Text] [Related]  

  • 15. CLINICAL FEATURES OF FLAT IRREGULAR PIGMENT EPITHELIAL DETACHMENT ASSOCIATED WITH CHOROIDAL NEOVASCULARIZATION IN CHRONIC CENTRAL SEROUS CHORIORETINOPATHY.
    Guo J; Tang W; Liu W; Chang Q; Xu G
    Retina; 2021 Jan; 41(1):199-207. PubMed ID: 32251241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of central serous chorioretinopathy: Expert panel discussion.
    Chhablani J; Anantharaman G; Behar-Cohen F; Boon C; Manayath G; Singh R
    Indian J Ophthalmol; 2018 Dec; 66(12):1700-1703. PubMed ID: 30451169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute lupus choroidopathy: multimodal imaging and differential diagnosis from central serous chorioretinopathy.
    Hasanreisoglu M; Gulpinar Ikiz GD; Kucuk H; Varan O; Ozdek S
    Int Ophthalmol; 2018 Feb; 38(1):369-374. PubMed ID: 28050729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dark and white lesions observed in central serous chorioretinopathy on optical coherence tomography angiography.
    De Bats F; Cornut PL; Wolff B; Kodjikian L; Mauget-Faÿsse M
    Eur J Ophthalmol; 2018 Jul; 28(4):446-453. PubMed ID: 29554817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SPIRONOLACTONE AS A THERAPEUTIC ALTERNATIVE FOR THE BULLOUS VARIANT OF CENTRAL SEROUS CHORIORETINOPATHY.
    Ramos-Yau EC; Muñoz-Domínguez E; Contreras-Mérida SP; Valencia-Londoño LM
    Retin Cases Brief Rep; 2020; 14(4):381-385. PubMed ID: 29595560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central serous chorioretinopathy mimicking as choroiditis.
    Panigrahi PK; Mahapatra MM; Minj A; Satapathy J; Samant S
    Clin Exp Optom; 2018 May; 101(3):420-421. PubMed ID: 29134698
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.